{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2023,10,29]],"date-time":"2023-10-29T05:13:45Z","timestamp":1698556425863},"reference-count":16,"publisher":"Wiley","issue":"1","license":[{"start":{"date-parts":[[2002,1,5]],"date-time":"2002-01-05T00:00:00Z","timestamp":1010188800000},"content-version":"vor","delay-in-days":1465,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Journal of Internal Medicine"],"published-print":{"date-parts":[[1998,1]]},"abstract":"<jats:p>Harbrecht U, Oldenburg J, Klein P, Weber D, Rockstroh J, Hanfland P (University of Bonn, Bonn; University of W\u00fcrzburg, W\u00fcrzburg; and Evangelische Diakonissen Anstalt Bremen, Bremen, Germany). Increased sensitivity of factor IX to phenprocoumon as a cause of bleeding in a patient with antiphospholipid antibody associated thrombosis. <jats:italic>J Intern Med<\/jats:italic> 1998; <jats:bold>243<\/jats:bold>: 73\u201377.<\/jats:p><jats:p>We report one patient who presented with a spontaneous bleeding complication under phenprocoumon therapy. Oral anticoagulation was initiated due to deep\u2010vein thrombosis which was attributed to an antiphospholipid antibody syndrome. Coagulation analysis revealed a strong and selective reduction of factor IX (F IX) activity to 1%, whereas the other vitamin K\u2010dependent factors (II, VII, X), the prothrombin time and International Normalized Ratio (INR) were within the therapeutic range. After withdrawal of phenprocoumon, all vitamin K\u2010dependent factors including F IX normalized. Because the patient suffered from a recurrence of thrombotic events, he was re\u2010exposed to phenprocoumon and the disproportionate decline of F IX was observed again. These findings indicate an increased sensitivitiy of F IX to vitamin K antagonists, representing an uncommon mechanism associated with bleeding complications under oral anticoagulant treatment.<\/jats:p>","DOI":"10.1046\/j.1365-2796.1998.00252.x","type":"journal-article","created":{"date-parts":[[2003,3,12]],"date-time":"2003-03-12T06:06:41Z","timestamp":1047449201000},"page":"73-77","source":"Crossref","is-referenced-by-count":6,"title":["Increased sensitivity of factor IX to phenprocoumon as a cause of bleeding in a patient with antiphospholipid antibody associated thrombosis"],"prefix":"10.1111","volume":"243","author":[{"family":"Harbrecht","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Oldenburg","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Klein","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Weber","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Rockstroh","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"family":"Hanfland","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"311","published-online":{"date-parts":[[2002,1,5]]},"reference":[{"key":"e_1_2_4_2_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM198212303072704"},{"key":"e_1_2_4_3_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199002153220703"},{"key":"e_1_2_4_4_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199504133321504"},{"key":"e_1_2_4_5_2","doi-asserted-by":"crossref","first-page":"14","DOI":"10.1055\/s-0038-1660009","article-title":"The antiphospholipid antibody syndrome.","volume":"17","author":"Barbui T","year":"1997","journal-title":"Haemostaseologie"},{"key":"e_1_2_4_6_2","doi-asserted-by":"crossref","first-page":"11210","DOI":"10.1016\/S0021-9258(18)33742-6","article-title":"Evidence that warfarin anticoagulant action involves two distinct reductase activities.","volume":"257","author":"Fasco MJ","year":"1982","journal-title":"J Biol Chem"},{"key":"e_1_2_4_7_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJM199106273242606"},{"key":"e_1_2_4_8_2","doi-asserted-by":"publisher","DOI":"10.1096\/fasebj.7.5.8462786"},{"key":"e_1_2_4_9_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1982.00479.x"},{"key":"e_1_2_4_10_2","doi-asserted-by":"publisher","DOI":"10.1161\/01.CIR.89.3.1469"},{"key":"e_1_2_4_11_2","doi-asserted-by":"crossref","first-page":"2854","DOI":"10.1182\/blood.V84.9.2854.2854","article-title":"Autoantibodies to phospholipid\u2010binding plasma proteins: a new view of lupus anticoagulants and other \u2018antiphospholipid\u2019 autoantibodies.","volume":"84","author":"Roubey RAS","year":"1994","journal-title":"Blood"},{"key":"e_1_2_4_12_2","doi-asserted-by":"publisher","DOI":"10.1055\/s-0038-1649901"},{"key":"e_1_2_4_13_2","first-page":"254","article-title":"Lupus anticoagulant and thrombosis.","volume":"15","author":"Lechner K","year":"1985","journal-title":"Hemostasis"},{"key":"e_1_2_4_14_2","doi-asserted-by":"publisher","DOI":"10.1016\/0049-3848(87)90088-0"},{"key":"e_1_2_4_15_2","doi-asserted-by":"publisher","DOI":"10.1111\/j.1365-2141.1990.00122.x-i1"},{"key":"e_1_2_4_16_2","doi-asserted-by":"publisher","DOI":"10.1046\/j.1365-2141.1997.2213036.x"},{"key":"e_1_2_4_17_2","doi-asserted-by":"publisher","DOI":"10.1172\/JCI118956"}],"container-title":["Journal of Internal Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2796.1998.00252.x","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1046%2Fj.1365-2796.1998.00252.x","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1046\/j.1365-2796.1998.00252.x","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,28]],"date-time":"2023-10-28T02:31:45Z","timestamp":1698460305000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1046\/j.1365-2796.1998.00252.x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[1998,1]]},"references-count":16,"journal-issue":{"issue":"1","published-print":{"date-parts":[[1998,1]]}},"alternative-id":["10.1046\/j.1365-2796.1998.00252.x"],"URL":"https:\/\/doi.org\/10.1046\/j.1365-2796.1998.00252.x","archive":["Portico"],"relation":{},"ISSN":["0954-6820","1365-2796"],"issn-type":[{"value":"0954-6820","type":"print"},{"value":"1365-2796","type":"electronic"}],"subject":[],"published":{"date-parts":[[1998,1]]}}}